I can comment on the vaccines that are currently approved. They are produced in Europe, and they are shipped from Europe to Canada through various means. Some of those products are also manufactured in the U.S. and other locations. At the current time, the U.S. production is aimed at the U.S. market.
Minister Anand at PSPC is very much engaged with the manufacturers, as she has indicated a number of times, to bring forward quantities into earlier quarters and to also look at diversifying as much as possible the point from where those vaccines come to reduce the risk. I think we're all very focused on what we learned this week from the EU and the executive order in the U.S. and what that could mean. There are a number of variables at play here, and they're all being considered to the best of our ability.